Oncogenic drivers dictate immune control of acute myeloid leukemia.
R. J. Austin, J. Straube, R. Halder, Y. Janardhanan, C. Bruedigam, M. Witkowski, L. Cooper, A. Porter, M. Braun, F. Souza-Fonseca-Guimaraes, S. A. Minnie, E. Cooper, S. Jacquelin, A. Song, T. Bald, , M. J. Bywater
This study shows that specific AML oncogenes influence immune responses and escape mechanisms, with NrasG12D promoting anti-leukemia immunity that can be counteracted by Myc.
bioRxiv · Feb 8, 2023Cancer Biology